ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 987

Autoimmune Susceptibility Genes Are Regulators of Gene Expression Response to ER Stress

William E. Bernal1, Michael P. Morley2 and Vivian G. Cheung3, 1Division of Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Pediatrics & Genetics, Howard Hughes Medical Institute, Chevy Chase, MD; University of Pennsylvania, Philadelphia, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), autoimmune diseases and genomics, BAFF

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Endoplasmic recticulum (ER) stress is caused by excessive demands on the protein-processing capacity of the ER; inefficiencies in response to ER stress lead to human diseases such as ankylosing spondylitis (AS). ER stress has been linked to inflammatory pathways. To study the role of ER stress in disease susceptibility, we identified the genes and pathways involved in ER stress response in human cells, assessed individual variation in these pathways, and mapped DNA sequence variants that influence ER stress response.

Methods: To study ER stress response in B-cells, we exposed the cells from 131 normal unrelated individuals to tunicamycin, a chemical inducer of ER stress, and measured changes in gene expression before and following ER stress. Then, to determine the genetic basis of variation in gene expression response to ER stress, we carried out genetic mapping using B-cells from members of 15 extended families.

Results: We identified 1,523 ER stress-responsive genes which showed at least 1.5 fold changes in gene expression following ER stress.  The results showed extensive individual variation in gene expression response to ER stress.  For instance, TNFSF13B (BAFF/Blys), a potent activator of B cells, has a mean induction of 1.6-fold but there is a 2.4-fold difference in its level between the individuals with the lowest and highest induction of this gene.  XBP1 and DDIT3 (CHOP), which encode key ER stress transcription factors, vary by 5-fold and 9-fold. From our linkage and association studies, we focused our analysis on 778 ER stress-responsive genes and identified DNA sequence variants that regulate the response of 497 of the genes, including TNFSF13B.  Regulators of gene expression response to ER stress include susceptibility genes for autoimmune diseases: BLK (systemic lupus erythematosus, rheumatoid arthritis, Kawasaki disease); SVIL (multiple sclerosis); ANTXR2, RUNX3 and ERAP1 (AS). Genes associated with neurodegenerative diseases in which ER stress is known to play a role in disease pathology—amyotrophic lateral sclerosis, Alzheimer disease, Parkinson disease—are also represented among the regulators.

Conclusion: These results allowed us to identify genes and their regulators involved in ER stress response in human B-cells. The presence of susceptibility genes for autoimmune diseases among the regulators identified in our study implicates ER stress in disease pathology. Identification of TNFSF13B as an ER stress-responsive gene in human B-cells provides further evidence of a link between ER stress and inflammation.


Disclosure:

W. E. Bernal,
None;

M. P. Morley,
None;

V. G. Cheung,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/autoimmune-susceptibility-genes-are-regulators-of-gene-expression-response-to-er-stress/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology